It's All About-Nonprofit Foundation-Mesa-Researching Type 1 Diabetes
The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. For now, doctors don’t know the exact reason that lead to T1D, but they do know that your genes play a role. They also know that Type 1 Diabetes can result when something in the environment, like a virus, tells your immune system to go after your pancreas. Most of people with T1D have signs of this attack, called autoantibodies. They are presented in almost everyone who has the condition when their blood sugar is high.
Type 1 diabetes can happen along with other autoimmune diseases, like Grave’s disease or vitiligo.
The symptoms are often subtle, but can become severe. They can be:
– Heavy thirst
– Increased hunger
– Nausea and vomiting
– Dry mouth
– Pain in your belly
– Frequent urination
– Unexplained weight loss (even though you’re eating and feel hungry)
– Fatigue (weak, tired feeling)
– Blurred vision
– Heavy, labored breathing (your doctor will call this Kussmaul respiration)
– Frequent infections of the skin, urinary tract, or vagina. List of all video credits is located here http://broadcaster.beazil.net/public/credits/youtube/videos/42226 The word “mesa” originally comes from the Spanish and Latin words for “table,” and the city of Mesa is certainly that; a rich table spread of variety, spice, and life. As the third largest city in the state of Arizona, Mesa offers some of the finest amenities available to the Valley, being a thriving major city while still retaining that small town or suburban atmosphere. Like most towns in the Phoenix major metropolitan area, Mesa is the spring training home of a Major League Baseball team; the Chicago Cubs. Mesa’s convenient proximity to the main freeways of the Phoenix metro area mean that even if you’re not a Cubs fan, you can easily get to any of the many sports venues in the Valley to see other teams play, as there’s almost always a game to catch somewhere in the Valley. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To draw the conclusion, let’s identify the main points –
young adult diabetes,Sodium–glucose cotransporter 2 inhibitors,Robert Wood Johnson IV,donate today,Glucose,VLDL cholesterol,methods to cure T1D,Insulin Pump Therapy,At Risk,Glipizide,Clinical Trial,Understanding Type 1,engage,Device,gestational diabetes mellitus,help,insulin dependent,Insulin detemir,Government Advocacy,Basal Insulin,high blood glucose,Managing a hypo,Aaron Kowalski,Restoration,dipeptidyl peptidase 4 inhibitors,blocking glucose reabsorption,glycemic control,DPP,secondary diabetes,hyperglycemic crisis,T1D Mentors,Team Cure Diabetes,Diabetes Control and Complications Trial,insulin glulisine,International,nonprofit funder,diabetic mastopathy,Casual Plasma Glucose Test,Advocacy,OneWalk,Novolin R,Promise Gala,advocating for government support,The Valentine State,The Aztec State,funding,SGLT2 inhibitors,Political advocacy,Treatment research,NDEP,undiagnosed diabetes,Insulin Pump,Mary Tyler Moore,become an advocate,diabetic retinopathy,using insulin,fasting plasma glucose.